Medical Design and Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech

ITRI introduces two medical breakthrough technologies: Collabody and iSmartweaR

November 4, 2016 By Abigail Esposito

itri-collabody-photo

Collabody is a new protein engineering platform for the effective delivery of anti-cancer drugs.

Industrial Technology Research Institute (ITRI), Taiwan’s largest high-tech applied research institutions, introduces two breakthrough medical technologies in cancer drug development and wearables: Collabody, a protein engineering platform for the effective delivery of anti-cancer drugs; and iSmartweaR smart clothing, which transforms ordinary fabrics into smart wearables allowing textile products to track vital signs without bodily contact.

Collabody is a new protein engineering platform for the effective delivery of anti-cancer drugs. Currently, anti-cancer drugs suffer from insufficient cross-linking activity with the target molecules on cancer cell surfaces which result in poor therapeutic efficacy.

ITRI’s Collabody with its recombinant fusion platform for making protein drugs with multiple binding capabilities solves this problem and enhances the therapeutic potency by attacking cancer cells through cross-linking with the targets. Its three target-binding domains, like three hands, enables increased binding strength and cross-linking potency and features further improvements in the triple collagen peptide-scaffold and antibody fragment fusion technology included within Collabody.

Collabody’s bispecific T cell collagen peptide-scaffold antibody are like three bridges. Each end of each bridge is connected to different antibodies, and cross-linked to specific molecules in immune cells and tumor cells.

This connection effectively activates T cells, and since T cells have the ability to distinguish between the body’s own cells and foreign matter, they won’t attack autologous cells. Activated T cells increase the chances of killing cancerous cells.

Most traditional “small molecular drugs” are like bombs, with all cells, including healthy ones, suffering the impact of the drug within a confined area. Monoclonal antibodies such as Collabody, however, are able to identify specific antigens in the body and attack those targets like a guided missile.

Consequently, in the course of treating cancer or autoimmune diseases, Collabody is able to kill specific cells, thereby reducing harm to other cells and diminishing side effects to the body.

“Collabody is being tested on laboratory animals, with significant effects especially in fighting lung cancer,” said Yio-Wha Shau, ITRI’s VP and general director of Biomedical Technology and Device Research Laboratories. “If clinical trials on a larger scale are approved, the drug delivery platform is expected to have applications in colon cancer, and head and neck cancers, among others. It is hoped that Collabody will be more effective in treating cancers than current approaches, enabling protein drugs to gradually become more commonly produced by the pharmaceutical community.”

itri-ismartwear-photo

iSmartweaR smart clothing, jointly developed by ITRI and ECLAT Textile, transforms ordinary fabrics into smart wearables.

iSmartweaR brings non-contact comfort for tracking vital signs
iSmartweaR smart clothing, jointly developed by ITRI and ECLAT Textile, transforms ordinary fabrics into smart wearables. It integrates nanosecond pulse near-field sensing technology (NPNS), with washable conductive fabrics allowing textile products to track vital signs without bodily contact.

NPNS features miniature low-power radar using Bluetooth transmission to connect with ICT systems. Its advantages are compact size, high sensitivity, high selectivity, high reliability, low price, low energy consumption and penetrability.

Conventional smart clothing uses conductive fibers or rubber as sensing electrodes, and cardiac electrical sensing modules have required at least two or more electrodes to contact the skin for capturing the heart’s electrophysiological signals. Such a limitation cannot compare to the non-contact comfort that ITRI’s iSmartweaR now offers.

ITRI’s smart clothing technology uses a single antenna radar sensing design that simultaneously detects human heartbeats, breathing rates and other activity levels all without causing any user discomfort. Using low-power microwave technology, iSmartweaR does not have direct contact with the skin, thus causing no direct pressure on the wearer’s body.

“iSmartweaR is significant and widely applicable,” said Hong-Dun Lin, manager of ITRI’s Center of Measurement Standards. “It can help prevent sudden death in infants by tracking their physiological parameters. It also analyzes a user’s average health data and can warn of abnormal fatigue levels. iSmartweaR can be used in individual sports training, long-term data analysis for senior citizen healthcare, and health monitoring for professionals such as police and firefighters. Therefore, not only is it practical for the general consumer but also for individuals in various professional fields.”

Industrial Technology Research Institute
itri.org

Related Articles Read More >

A portrait of AcuityMD co-founder and CEO Michael Monovoukas
Device commercialization platform AcuityMD raises $31M Series A to fund R&D engineer hiring
Harvard Science and Engineering Complex SEC SEAS Harvard John A. Paulson School of Engineering and Applied Sciences
Here’s where Harvard’s engineering dean sees medtech research going
An illustration of a cloud-shaped room filled with medical devices
The cloud is transforming medtech: Amazon, Microsoft, Google, J&J, Philips and GE Healthcare leaders explain
MIT GI pressure detection device
MIT researchers think their tube-based device could improve gastrointestinal disorder diagnosis

DeviceTalks Weekly.

May 20, 2022
DeviceTalks Boston Post-Game – Editors’ Top Moments, Insulet’s Eric Benjamin on future of Omnipod 5
See More >

MDO Digital Edition

Digital Edition

Subscribe to Medical Design & Outsourcing. Bookmark, share and interact with the leading medical design engineering magazine today.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
DeviceTalks

DeviceTalks is a conversation among medical technology leaders. It's events, podcasts, webinars and one-on-one exchanges of ideas & insights.

DeviceTalks

New MedTech Resource

Medical Tubing

Enewsletter Subscriptions

Enewsletter Subscriptions

MassDevice

Mass Device

The Medical Device Business Journal. MassDevice is the leading medical device news business journal telling the stories of the devices that save lives.

Visit Website
MDO ad
Medical Design and Outsourcing
  • MassDevice
  • DeviceTalks
  • MedTech 100 Index
  • Medical Tubing + Extrusion
  • Drug Delivery Business News
  • Drug Discovery & Development
  • Pharmaceutical Processing World
  • R&D World
  • About Us/Contact
  • Advertise With Us
  • Subscribe to Print Magazine
  • Subscribe to E-newsletter
  • Attend our Monthly Webinars
  • Listen to our Weekly Podcasts
  • Join our DeviceTalks Tuesdays Discussion

Copyright © 2022 WTWH Media, LLC. All Rights Reserved. Site Map | Privacy Policy | RSS

Search Medical Design & Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech